Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy
International Immunopharmacology（2020）
Abstract
•Our patient is the first case of nivolumab related central diabetes insipidus.•Hypovolemic hypernatremia can be rare manifestation of central diabetes insipidus.•Nivolumab can rarely be associated with immune related hypophystis.•Central diabetes insipidus is rare in the context of immune related hypophysitis.
MoreTranslated text
Key words
Central diabetes insipidus,Hypophysitis,Hypernatremia,Nivolumab,Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined